Benjamin Hohl
ELVNBenjamin Hohl serves as officer: CHIEF FINANCIAL OFFICER at Enliven Therapeutics, Inc. (ELVN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Benjamin Hohl's Insider Trading at Enliven Therapeutics, Inc. (ELVN)
Buys
0 · $0.00
Sells
37 · $3.54M
Total Shares Bought
0
Total Shares Sold
150,082
Related Insiders
Lori Anne Kunkel
director
ELVNSell · Jul 8, 2026
ORBIMED ADVISORS LLC
10 percent owner
ELVNSell · Jun 24, 2026
Helen Louise Collins
officer: CHIEF MEDICAL OFFICER
ELVNSell · Jun 22, 2026
Richard A. Heyman
Director
ELVNSell · Feb 19, 2026
Joseph P Lyssikatos
officer: CHIEF SCIENTIFIC OFFICER
ELVNSell · Feb 10, 2026
Anish Patel
officer: CHIEF OPERATING OFFICER
ELVNSell · Jan 13, 2026
Samuel Kintz
PRESIDENT AND CEO
ELVNSell · Nov 17, 2025